性别与急性冠脉综合征:表现与结局差异综述
该综述总结急性冠脉综合征(ACS)在性别与生理性别上的差异证据,指出女性ACS结局仍劣于男性,存在就诊与系统延迟更高、侵入性治疗与药物治疗更少等问题;基线冠脉解剖与功能存在性别差异,但指南推荐基于男性占多数的试验数据;年轻女性预后尤其不利,心理社会因素、性别特异性血管与神经应激反应及表观遗传修饰可能参与机制。
要点
- 女性ACS患者结局仍劣于男性,就诊与系统延迟更高、侵入性治疗和药物治疗更少。
- 指南推荐基于男性占多数的试验数据,男女按同一标准治疗但基线冠脉解剖与功能存在性别差异。
- 年轻女性ACS预后尤其不利,心理社会因素、性别特异性应激反应和表观遗传修饰可能参与。
核心结论
- 女性ACS临床结局仍劣于男性,且年轻女性预后尤其不利。
- 指南推荐基于男性占多数的试验数据,男女按同一标准治疗但基线冠脉解剖与功能存在性别差异。
- 心理社会因素、性别特异性血管与神经应激反应及表观遗传修饰可能调节男女疾病进程。
研究设计与样本
- 综述,总结性别与生理性别在ACS血管生物学、临床表现和结局方面的当代证据。
主要发现
- 女性ACS患者经历更高的患者与系统延迟,接受侵入性治疗和药物治疗更少。
- 男女基线冠脉解剖与功能存在性别差异,但指南推荐基于男性占多数的实验与临床试验数据。
- 年轻女性ACS预后尤其不利,该人群仍存在大量未解问题。
临床怎么用
- 临床应关注女性ACS患者的就诊与系统延迟,并重视其侵入性治疗和药物治疗不足的问题。
- 对年轻女性ACS患者应警惕其尤其不利的预后。
- 认识男女基线冠脉解剖与功能差异,在遵循指南同时关注性别特异性因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Although health disparities in women presenting with acute coronary syndrome (ACS) have received growing attention in recent years, clinical outcomes from ACS are still worse for women than for men. Women continue to experience higher patient and system delays and receive less aggressive invasive treatment and pharmacotherapies. Gender- and sex-specific variables that contribute to ACS vulnerability remain largely unknown. Notwithstanding the sex differences in baseline coronary anatomy and function, women and men are treated the same based on guidelines that were established from experimental and clinical trial data over-representing the male population. Importantly, younger women have a particularly unfavourable prognosis and a plethora of unanswered questions remains in this younger population. The present review summarizes contemporary evidence for gender and sex differences in vascular biology, clinical presentation, and outcomes of ACS. We further discuss potential mechanisms and non-traditional risk conditions modulating the course of disease in women and men, such as unrecognized psychosocial factors, sex-specific vascular and neural stress responses, and the potential impact of epigenetic modifications.
引用
- Haider A, Bengs S, Luu J, et al. Sex and gender in cardiovascular medicine: presentation and outcomes of acute coronary syndrome. Eur Heart J. 2020. PMID: 31876924. doi:10.1093/eurheartj/ehz898
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。